Spatial MS multiomics on clinical prostate cancer tissues
Analytical and Bioanalytical Chemistry · 2024-03 · 416 (7) · 1745-1757
DOI: 10.1007/s00216-024-05178-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, online erschienen am 07.02.2024. Verfasst von Jacob X M Truong und 6 weiteren Autor:innen. Beteiligte Einrichtung: The University of Adelaide, North Terrace, Adelaide, SA, 5000, Australia. Hauptthemen laut MEDLINE: Multiomics, Prostatic Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Mass spectrometry (MS) and MS imaging (MSI) are used extensively for both the spatial and bulk characterization of samples in lipidomics and proteomics workflows. These datasets are typically generated independently due to different requirements for sample preparation. However, modern omics technologies now provide higher sample throughput and deeper molecular coverage, which, in combination with more sophisticated bioinformatic and statistical pipelines, make generating multiomics data from a single sample a reality. In this workflow, we use spatial lipidomics data generated by matrix-assisted laser desorption/ionization MSI (MALDI-MSI) on prostate cancer (PCa) radical prostatectomy cores to guide the definition of tumor and benign tissue regions for laser capture microdissection (LCM) and bottom-up proteomics all on the same sample and using the same mass spectrometer. Accurate region of interest (ROI) mapping was facilitated by the SCiLS region mapper software and dissected regions were analyzed using a dia-PASEF workflow. A total of 5525 unique protein groups were identified from all dissected regions. Lysophosphatidylcholine acyltransferase 1 (LPCAT1), a lipid remodelling enzyme, was significantly enriched in the dissected regions of cancerous epithelium (CE) compared to benign epithelium (BE). The increased abundance of this protein was reflected in the lipidomics data with an increased ion intensity ratio for pairs of phosphatidylcholines (PC) and lysophosphatidylcholines (LPC) in CE compared to BE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The University of Adelaide, North Terrace, Adelaide, SA, 5000, Australia.
- South Australian Health and Medical Research Institute (SAHMRI), North Terrace, Adelaide, South Australia, 5000, Australia.
- Freemasons Centre for Male Health and Wellbeing, University of Adelaide, North Terrace, Adelaide, South Australia, 5000, Australia.
- South Australian immunoGENomics Cancer Institute (SAiGENCI), North Terrace, Adelaide, South Australia, 5000, Australia.
- Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, 5042, Australia.
- The University of Adelaide, North Terrace, Adelaide, SA, 5000, Australia. Paul.Trim@sahmri.com.
Zitieren
APA
Truong, J. X. M., Rao, S. R., Ryan, F. J., Lynn, D. J., Snel, M. F., Butler, L. M., & Trim, P. J. (2024). Spatial MS multiomics on clinical prostate cancer tissues. Analytical and Bioanalytical Chemistry, 416(7), 1745-1757. https://doi.org/10.1007/s00216-024-05178-z
Vancouver
Truong JXM, Rao SR, Ryan FJ, Lynn DJ, Snel MF, Butler LM, et al. Spatial MS multiomics on clinical prostate cancer tissues. Analytical and Bioanalytical Chemistry. 2024;416(7):1745-1757. doi:10.1007/s00216-024-05178-z
BibTeX
@article{Truong2024,
author = {Truong, Jacob X M and Rao, Sushma R and Ryan, Feargal J and Lynn, David J and Snel, Marten F and Butler, Lisa M and Trim, Paul J},
title = {Spatial MS multiomics on clinical prostate cancer tissues},
journal = {Analytical and Bioanalytical Chemistry},
year = {2024},
volume = {416},
number = {7},
pages = {1745--1757},
doi = {10.1007/s00216-024-05178-z}
}
EUVIMED